These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2994910)

  • 1. Changes in serum osteocalcin associated with parathyroid hormone infusion in X-linked hypophosphatemic rickets.
    Cole DE; Gundberg CM
    Clin Chim Acta; 1985 Sep; 151(1):1-7. PubMed ID: 2994910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum parathyroid hormone concentrations in hypophosphataemic vitamin D resistant rickets.
    Fanconi A; Fischer JA; Prader A
    Helv Paediatr Acta; 1974 Aug; 29(3):187-94. PubMed ID: 4369169
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
    Bai X; Miao D; Li J; Goltzman D; Karaplis AC
    Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum osteocalcin as an index of altered bone metabolism.
    Kruse K; Kracht U
    Eur J Pediatr; 1986 Apr; 145(1-2):27-33. PubMed ID: 3015628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG; Quigley R; Baum M
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
    J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone secretion in familial vitamin-D-resistant rickets.
    Reitz RE; Weinstein RL
    N Engl J Med; 1973 Nov; 289(18):941-5. PubMed ID: 4355232
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
    Lewy JE; Cabana EC; Repetto HA; Canterbury JM; Reiss E
    J Pediatr; 1972 Aug; 81(2):294-300. PubMed ID: 4339535
    [No Abstract]   [Full Text] [Related]  

  • 11. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
    McElduff A; Posen S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
    Short E; Morris RC; Sebastian A; Spencer M
    J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteocalcin has limited usefulness as a diagnostic marker for rickets.
    Daniels ED; Pettifor JM; Moodley GP
    Eur J Pediatr; 2000 Oct; 159(10):730-3. PubMed ID: 11039126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor (FGF)-23 and hypophosphatemic rickets/osteomalacia.
    Fukumoto S; Yamashita T
    Endocr J; 2001 Dec; 48(6):603-10. PubMed ID: 11873859
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum osteocalcin concentrations in patients with rheumatoid arthritis.
    Pietschmann P; Machold KP; Wolosczuk W; Smolen JS
    Ann Rheum Dis; 1989 Aug; 48(8):654-7. PubMed ID: 2789500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.
    Chen C; Carpenter T; Steg N; Baron R; Anast C
    Pediatrics; 1989 Aug; 84(2):276-80. PubMed ID: 2787497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats.
    Lian JB; Carnes DL; Glimcher MJ
    Endocrinology; 1987 May; 120(5):2123-30. PubMed ID: 3494594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.